IDYA (ideayabio.com) מקדם שווי פעילות להכנסות

סמלים רשמיים של חברת IDEAYA Biosciences Inc (IDYA)

IDEAYA Biosciences (IDYA) is betting on robust R&D and strategic alliances with pharma behemoths without pursuing mergers. However, geopolitics creates risks of disrupting supply chains for rare reagents. Diversification through targeted therapy for various mutations helps expand the pipeline. This EV/Sales chart captures the market value relative to revenue, where a metric value of 47130.03 determines the current investment potential.

ideayabio.com (IDYA): מכפיל EV/Sales מ-23.11.2025 עד 20.11.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור IDEAYA Biosciences, Inc. (IDYA)

- מחיר ותחזית קונצנזוס למחירים:
- מדדי הערכת שווי שוק של העסק:
הערכת שווי פונדמנטלית של החברה:IDEAYA Biosciences IDYA
דוגמת מוצר של ideayabio.com

IDEAYA Biosciences (IDYA) developments in synthetic lethality create the potential for establishing premium pricing power in the future, despite the current absence of commercial sales. By analyzing changes in EV/Sales, an investor assesses the business value inclusive of net debt relative to revenue, where a stagnant indicator signals exhausted market momentum and a latent risk of a sharp, volatile price breakout.